Back
Zevra Therapeutics Stock Predictions
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.
Sell
24
ZVRA
Zevra Therapeutics
Last Price:
$7.48
Seasonality Move:
-6.77%
7 Day Trial
ALL ACCESS PASS
$
7
Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Zevra Therapeutics Stock Forecast
-
Over the next 52 weeks, Zevra Therapeutics has on average historically risen by 2% based on the past 9 years of stock performance.
-
Zevra Therapeutics has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
-
Is Zevra Therapeutics Stock Undervalued?The current Zevra Therapeutics [ZVRA] share price is $7.32. The Score for ZVRA is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
-
ZVRA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Zevra Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Zevra Therapeutics has on average historically risen by 2% based on the past 9 years of stock performance.
Zevra Therapeutics Stock Rating
Sell
24
Zevra Therapeutics (ZVRA)
is a Sell
Is Zevra Therapeutics overpriced?
-
Zevra Therapeutics has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
Zevra Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
zevra.com
52-Week Data
52-Week High:
9.76
52-Week Low:
4.20
Prediction Charts
Market Cap:
396.1M
Price in USD:
7.32
Volume:
398.6K
Beta:
1.80
Technical Analysis
SMA50:
7.89
SMA100:
8.31
SMA200:
7.55
52-Wk Change:
41.86%
Stock Predictions
-
Is Zevra Therapeutics stock public?Yes, Zevra Therapeutics is a publicly traded company.
-
What is the Zevra Therapeutics stock quote today?The Zevra Therapeutics stock price is 7.32 USD today.
-
How to buy Zevra Therapeutics stock online?You can buy Zevra Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-13 | 7.84 | 7.94 | 8.29 | 7.62 |
| Mar-14 | 7.96 | 8.31 | 8.49 | 7.77 |
| Mar-17 | 8.29 | 8.35 | 8.42 | 8.18 |
| Mar-18 | 8.27 | 7.97 | 8.40 | 7.96 |
| Mar-19 | 7.94 | 7.95 | 8.10 | 7.84 |
| Mar-20 | 7.88 | 8.01 | 8.09 | 7.81 |
| Mar-21 | 7.91 | 8.01 | 8.14 | 7.87 |
| Mar-24 | 8.33 | 8.21 | 8.33 | 8.07 |
| Mar-25 | 8.16 | 8.15 | 8.22 | 7.95 |
| Mar-26 | 8.15 | 7.85 | 8.21 | 7.78 |
| Mar-27 | 7.88 | 7.96 | 8.00 | 7.80 |
| Mar-28 | 7.99 | 7.85 | 7.99 | 7.77 |
| Mar-31 | 7.71 | 7.49 | 7.75 | 7.45 |
| Apr-1 | 7.63 | 7.32 | 7.63 | 7.26 |
Zevra Therapeutics Earnings
Zevra Therapeutics Earnings Report: Per Share Zevra Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Zevra Therapeutics Forecast Revenue Growth
Zevra Therapeutics Stock Analysis: Historical quarterly revenues per share for Zevra Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.04 per share, and an increase next year of $0.54 per share.
* Zevra Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.